EARNING RECAP

Cummins Inc.

CMI 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 ex-items $3.48 est. $3.81 $6.1B est. $6.09B -.31% ($149.35 closing price) $150.97 $146.24 sees FY19 revenues flat to up 4% est. $24.4B, sees FY19 EBITDA in the range of $15.75 to $16.25; CMI expects to return 75% of Operating Cashflow to shareholders in form of dividend or share repurchase
Q3 ex-items $4.05 est. $3.76 $5.94B est. $5.95B +2.30% ($134.40 closing price) $134.99 $124.72 backs FY18 revenue view of +15%- 17%
Q2 $3.32 est. $3.63 $6.1B est. $5.82B +.23% ($91.23 closing) $91.38 $90.78 boosts FY18 revenue view to 15%-17% from 10%-14%
Q1 adjusted $2.43 est. $2.92 $5.6B est. $5.18B +.11% ($87.15 closing) $87.25 $86.46 boosts FY18 revenue view to up 10%-14% vs. prior view of up 4%-8%
CMI 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 ($1.65) includes 1 time charges related to tax reform est. $2.67 $5.5B est. $5.24B -2.34% 174.83 180.60 Plans to return at least 50% of Operating cash Flow to share holders in 2018
Q3 $2.71 est. $2.46 $5.3B est. $4.79B -1.92% 177.95 172.11 guides FY '17 revenue viewto 14%-15% from 9%-11%;

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.